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ABSTRACT 
Ethnopharmacological relevance: In contrast to other leguminous plants generally used as 
food, Rhynchosia volubilis Loureiro, a small soybean with a black seed coat, has been used as 
a traditional oriental remedy for various human diseases in Eastern Asia. In this study, we 
demonstrated the protective effect of R. volubilis against dry eye disease. 
Aim of the study: We aimed to investigate whether a standardized ethanol extract of R. 
volubilis (EERV) can protect the cornea in a benzalkonium chloride (BAC)-induced mouse 
dry eye model. 
Materials and Methods: Experimental dry eye was induced by the instillation of 0.2% BAC 
on mouse cornea. A standardized ethanol extract of R. volubilis (EERV) was orally 
administered following BAC treatment. The positive control group was treated with 
commercial eye drops. Fluorescein staining, tear break-up time (BUT), and hematoxylin and 
eosin staining were evaluated on the ocular surface. Squamous metaplasia and apoptosis in 
the corneal epithelial layer were detected by immunostaining. Furthermore, the protein 
expression of cytochrome c, Bcl-2, and Bax was determined.  
Results: EERV treatment significantly improved fluorescein scoring, BUT, and smoothness in 
the cornea compared to the vehicle group. In addition, EERV inhibited squamous metaplasia 
and apoptosis in the cornea. The expression of cytochrome c and Bax was upregulated, while 
that of Bcl-2 was downregulated in the vehicle group compared with that in the control group. 
However, EERV treatment inhibited the expression of cytochrome c and Bax, while that of 
Bcl-2 was improved.  
Conclusion: Standardized EERV could be a beneficial candidate for the treatment of dry eye 
disease. 
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BAC, Benzalkonium chloride; BSA, bovine serum albumin; BUT, tear break-up time; CMC, 
carboxymethyl cellulose; DE, dry eye; DEWS, dry eye workshop; ECL, enhanced 
chemiluminescent; EERV; ethanol extract of R. volubilis; H&E, hematoxylin and eosin; HLA, 
human leukocyte antigen; IL, interleukin; LOD, limits of detection; LOQ, limits of 
quantification; MCP-1, monocyte chemoattractant protein-1; PBST, phosphate-buffered 
saline with Triton-X100; PFA, paraformaldehyde; ROS, reactive oxygen species; RSDs, 
relative standard deviations; TFOS, tear film and Ocular surface society; TUNEL, terminal 
deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end-labeling; UV, ultraviolet;  
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1. Introduction 
Dry eye (DE) is a disorder of the tear film and ocular surface, which results in increased 
osmolality and inflammation as updated by the 2017 report of Tear Film & Ocular Surface 
Society (TFOS) and the Dry Eye Workshop II (DEWS II) (Craig et al., 2017). DE can cause 
discomfort, visual disturbance, and tear film instability with potential damage to the ocular 
surface owing to inadequate tear secretion and excessive evaporation of the tear film (Lemp 
et al., 2007). The specific mechanism of DE is unclear, but inflammation may have a major 
role in the pathogenesis of DE. It can lead to DE-related ocular complications, such as 
structural damage of the corneal epithelial layer, squamous metaplasia, and 
neovascularization (Bhavsar et al., 2011; Chotikavanich et al., 2009; Lam et al., 2009; 
Pflugfelder et al., 2000; Solomon et al., 2001; Tishler et al., 1998; Xu et al., 1996; Yoon et al., 
2007).  
Oxidative stress is commonly known to be a risk factor associated with anterior eye 
disorders, such as DE, benzalkonium chloride (BAC)-induced as well as tobacco smoke-
induced ocular surface damage (Kruk et al., 2015; Ogawa, 2013; Rosin and Bell, 2013). 
Commercial ophthalmic solutions contain BAC, which is the most commonly used 
preservative for preventing microbial contamination (Yu et al., 2008). However, chronic 
exposure to BAC leads to the induction of excessive generation of reactive oxygen species 
(ROS), including hydrogen peroxide (H2O2) and superoxide radical (O2
*-
) (Guenoun et al., 
2005). High levels of ROS accelerate the generation of pro-inflammatory cytokines, 
chemokines, and metalloproteinases that appear to initiate an inflammatory cascade and 
apoptotic cell death in the cornea (Luo et al., 2004; Nita and Grzybowski, 2016; Padgett et al., 
2013). These processes were observed in DE owing to a change in the quality and quantity of 
tear fluid. (Sonawane et al., 2012; Stevenson et al., 2012).  
Several studies have reported that antioxidants may prevent ocular surface damage 
induced by oxidative stress, thereby reducing the symptoms of DE (Andrade et al., 2014; 
Gatell-Tortajada, 2016; McCusker et al., 2016).  
Rhynchosia volubilis Loureiro, a small black bean, is a perennial climbing herb growing 
in mountains and fields in Korea, China, Japan, and Vietnam. While other members of the 
leguminous family are generally utilized as food, R. volubilis is used as a traditional oriental 
remedy for neuralgia, kidney disease, postmenopausal osteoporosis, and senile dementia 
(Kim, S.J. et al., 2007; Kinjo et al., 2001; Park et al., 2016; Yim et al., 2009). R. volubilis was 
previously reported to exhibit strong anti-oxidative activities, anti-obesity effect, proliferative 
activities on human osteoblastic cells, and anti-proliferative activities against gastric 
adenocarcinoma (Jeon et al., 2014; Kim, H.J. et al., 2007; Kim et al., 2005; Kim, S.J. et al., 
2007; Kinjo et al., 2001; Shin et al., 2008). Moreover, it has been considered a major 
medication in contraceptive prescriptions owing to its spermicidal activity (Guan et al., 2014).  
In Eastern Asia, R. volubilis was eaten for obtaining a clearer and better vision 
(JXUTCM, 1970). The activity of R. volubilis against eye diseases such as eye pain and 
blurred vision has been reported in the Herbal Handbook (Quattrocchi, 2012). R. volubilis 
contains an abundance of bioactive constituents including anthocyanins (cyanidin-3-
glucoside and delphinidin), isoflavonoids (daidzein , calycosin, biochanin A, and genistin), 
flavonoids (quercetin, epicatechin, tricin, and apigenin), polysaccharides, and peptides (Guo 
Yanyan, 2011; Hong et al., 2016; Jeon et al., 2014; Kim, H.J. et al., 2007; Yoshida et al., 
1996).  
Anthocyanins from the seed coat of black soybean has been reported to be effective in 
reducing retinal degeneration and cyanidin-3-O-glucoside, the dominant anthocyanin 
component in R. volubilis, has been reported to increase regeneration of rhodopsin in rod 
photoreceptors (Matsumoto et al., 2003; Paik et al., 2012; Tirupula et al., 2009; Yanamala et 
al., 2009). In addition, isoflavonoids and flavonoids have been previously shown to exhibit 
protective effects against DE and corneal neovascularization (Joussen et al., 2000; Kim, K.A. 
et al., 2016; Kruse et al., 1997; Yang et al., 2016). From these results, black soybean could be 
a beneficial agent for various ocular diseases. Despite being a potential candidate, the 
protective effect of R. volubilis against DE has not yet been reported.  
Therefore, we investigated whether a standardized ethanol extract of R. volubilis (EERV) 
was able to protect the cornea in a BAC-induced mouse DE model.  
 
2. Materials and methods  
2.1 Reagents  
All solvents were purchased from Fisher Scientific (Pittsburgh, PA). The standard, 
cyanidin 3-O-glucoside (1), was obtained from J & H chemical (Hangzhou, China). (-)-
Epicatechin (2), daidzin (3), genistin (4), and all other reagents were purchased from Sigma-
Aldrich (St. Louis, MO). The mounting medium was purchased from Vector Laboratories 
(Burlingame, CA). Bcl-2, β-actin, and HRP-conjugated IgG antibodies were purchased from 
Santa Cruz (Santa Cruz, CA). Alexa 488-conjugated and Alexa 594-conjugated antibodies 
were purchased from Invitrogen (Carlsbad, CA). Cytochrome c and Bax antibodies were 
purchased from Cell Signaling Technology (Beverly, MA). Cytokeratin-10 was purchased 
from Abcam (Cambridge, MA). HLA-DR was purchased from Biorbyt (San Francisco, CA). 
Zoletil and Rumpun were purchased from Virbac Laboratories (Fort Worth, TX) and Bayer 
(Newbury, UK), respectively.  
2.2 Plant material 
The seeds of R. volubilis were provided from Highland Agriculture Research Center, 
National Institute of Crop Science, Pyeongchang, South Korea. R. volubilis has been checked 
with http://www.theplantlist.org (Record 38957). A voucher specimen (KISTGN-RN-2016-
003) has been deposited at the KIST Gangneung Institute. Dried R. volubilis seeds were 
ground into powder (1 kg) and extracted twice with 5 L of 70% ethanol at 25°C for 3 h in an 
ultrasonic cleaning bath (model RK 158s, Bandelin, Berlin, Germany). The extracts were 
filtered through Whatman no. 1 filter paper, and the combined filtrate was concentrated to 
dryness by rotary evaporation at 40°C to obtain 50.4 g of EERV. Then, EERV was stored at -
20°C.  
2.3 Malonate constituents 
Separation of EERV was performed by reverse-phase HPLC chromatography on a Gilson 
semi-preparative HPLC system (Middleton, WI) equipped with a 321 pump and UV/VIS-155 
HPLC detector. EERV (1 g) was dissolved in 5 mL MeOH and separated on a YMC packpro 
C18 column (5 μm particle size, 250 × 20 mm, YMC Co., Japan) with an acetonitrile (A)-
water (B) gradient (25–56% A for 0–20 min, 56–95% A for 20–25 min, 10 mL/min, 260 nm) 
to yield 4.2 mg of 6″-O-malonyldaidzin (5) (tR = 13.9 min) and 7.8 mg of 6″-O-
malonylgenistin (6) (tR = 17.2 min). These compounds were identified by the Varian 500 
MHz NMR system (Palo Alto, CA) and Thermo Fisher Scientific LCQ FLEET ion trap mass 
spectrometer (San Jose, CA).  
2.4 HPLC- diode array detector (DAD)/MS analysis  
HPLC-DAD/MS was used for the identification of the major constituents of EERV as 
well as the quantitative analysis of compounds 1-6. Chromatographic separation was 
performed with a YMC pack pro C18 column (3 μm particle size, 150 × 4.6 mm I.D., YMC 
Co., Japan) using the Agilent Series 1200 liquid chromatography system (Agilent, CA). The 
HPLC solvent consisted of 0.1% formic acid in acetonitrile (solvent A) and 0.1% formic acid 
in water (solvent B). The separation was performed with a linear gradient (5% A for 0–1 min, 
5–40% A for 1–26 min, 40–95% A for 26–30 min, 95% A for 30–33 min, 95–5% A for 33–35 
min) at a flow rate of 1 mL/min. The absorbance was monitored at 260, 280, and 520 nm. 
The mass spectra were obtained using LCQ FLEET ion trap mass spectrometer with an 
electrospray ionization source (Thermo Fisher Scientific Inc., CA). The mass spectrometer 
conditions were as follows: positive ion mode; mass range, m/z 200−800; capillary voltage, 
10.0 V; tube lens, 45 V; sheath gas flow rate (N2), 50 arbitrary units; auxiliary gas flow rate 
(N2), 12 arbitrary units; capillary temperature, 350°C. 
2.5 Experimental DE model 
This study was approved by the Animal Care and Use Committee of KIST (No. 2016-
063). All the procedures were performed at the Korea Institute of Science and Technology 
(KIST) Gangneung Institute in agreement with the Association for Research and Vision in 
Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision 
Research guidelines. We used male BALB/c mice (6-week-old, 20–25 g) purchased from 
Central Lab (Gyonggi-do, Korea). The animals were housed in cages with aspen bedding at 
23 ± 0.5°C and 10% humidity in a 12:12 h light-dark cycle. Pelleted food and tap water were 
provided ad libitum. 
An experimental DE model was induced by the topical treatment of BAC (Kim, K.A. et 
al., 2016; Lin et al., 2011; Xiao et al., 2012). The left eyes of the mice were instilled with 5 
µL of 0.2% BAC, twice daily (10 AM and 10 PM) for 14 days. Thirty mice were randomly 
divided into control, DE (0.2% BAC-treated, alone), 10 mg/kg EERV (with 0.2% BAC), 50 
mg/kg EERV (with 0.2% BAC), and positive control (commercial eye drops with 0.2% BAC) 
groups, comprising six mice each. The control group was instilled with an equal volume (5 
µL) of physiological saline.  
DE was pre-induced by BAC for 3 days and administrative processing was conducted. 
EERV, physiological saline, and commercial eye drops were administered three days later for 
11 days. EERV (10 or 50 mg/kg body weight) was dissolved in distilled water with 0.5% 
carboxymethyl cellulose (CMC) and administered daily via oral gavage. The positive control 
group was instilled with commercial eye drops (Refresh Plus
® 
preservative-free, Allergan, 
CA) four times daily (11 AM, 3 PM, 7 PM, and 11 PM). The control, DE, and positive 
control groups orally received 0.5% CMC solution alone via gavage throughout the 
experimental period.  
After evaluation of BUT and fluorescein staining, the animals were sacrificed by cervical 
dislocation at 14 days. The left eyes were enucleated and immediately frozen in liquid 
nitrogen (Western blot analysis; n= 3 eyes per group) or fixed with 4% paraformaldehyde 
solution (Histological analysis; n= 3 eyes per group) at room temperature. 
 
2.6 Tear break-up time (BUT) 
After anesthesia of the mice with an intraperitoneal injection of a mixture of Zoletil and 
Rompun, the tear break up time (BUT) was measured on the ocular surface. 
To examine BUT, 2% fluorescein (Alcon Research Ltd, PA) was instilled in the 
conjunctival sac, and the eyelids were closed manually 34 times. Then, the ocular surface 
was evaluated under a slit lamp microscope (HaagStreit, Germany). At the first appearance 
of a dry sign, BUT was recorded (in seconds). 
2.7 Fluorescein staining 
Fluorescein staining was performed by applying fluorescein solution in the conjunctival 
sac after recording the BUT score. The corneal surface was divided into four areas that were 
scored separately from 0 to 4 in a blind fashion using the 2017 TFOS DEWS II-
recommended grading system (Wolffsohn et al., 2017; Zhang et al., 2014). 
2.8 Histological examination  
Whole eye tissue was fixed in 4% paraformaldehyde solution for 24 h. The tissues were 
embedded with paraffin and cut into 4 μm sections. The section tissues were deparaffinized in 
xylene, rehydrated in 95, 70, 50, and 30% ethanol, and dipped in distilled water for 10 min. 
To stain the nuclei, the sections were dipped in 0.1% hematoxylin buffer for 8 min at room 
temperature, and then washed 3 times with PBS. 1% Eosin Y buffer was used for staining the 
cytoplasm. The sections were dipped in 1% Eosin Y buffer for 1 min at room temperature. 
After washing with tap water, the section slides were dehydrated through 30, 50, 70, and 95% 
ethanol, followed by xylene. The section slides were subsequently mounted in mounting 
medium and sealed. Hematoxylin and eosin (H&E) staining was performed under a light 
microscope (Olympus, Japan) to evaluate the morphological changes. 
2.9 Immunostaining 
Paraffin was removed from the corneal sections with xylene. Then, the sections were 
rehydrated in 95, 70, 50, and 30% ethanol, and dipped in distilled water for 10 min. The 
sections were incubated in 10 mM citrate buffer (pH 6.0) for 3 min and heated in a 
microwave oven for three exposure cycles of 5 min each. Next, the sections were cooled in an 
ice bath and incubated with 5% hydrogen peroxide in PBS for 10 min at room temperature. 
After washing 3 times with PBS, the sections were blocked in blocking solution for 1 h and 
incubated with cytokeratin-10 (diluted 1:200) and human leukocyte antigen DR (HLA-DR; 
diluted 1:200) primary antibodies at 4°C overnight. Subsequently, the sections were washed 
with PBS containing 0.05% Triton-X100 and incubated with anti-rabbit Alexa 488 (diluted 
1:500) and anti-mouse Alexa 594 (diluted 1:500) secondary antibodies. The sections were 
washed 3 times, and mounted in Vector mounting medium with DAPI. Immunostaining was 
examined using confocal microscopy (Leica, Wetzlar, Germany).  
2.10 TUNEL staining 
Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling 
(TUNEL) assay was performed using an in situ TUNEL detection kit (Roche, UK), according 
to the manufacturer’s instructions. The apoptotic cells were detected by their dark nuclear 
staining (TUNEL-positive; Green) using confocal microscopy (Leica, Wetzlar, Germany).  
2.11 Western blot analysis 
Protein extraction from the corneal and conjunctival tissues was performed according to 
the reagent instruction (RIPA buffer, Sigma, MO). Equal amounts of total proteins were 
separated on SDS-PAGE gel and transferred onto polyvinylidene difluoride (PVDF) 
membranes (Bio-Rad, CA). Nonspecific binding sites were blocked with 5% skim milk, and 
then incubated overnight with cytochrome c (diluted 1:2000), Bcl-2 (diluted 1:2000), Bax 
(diluted 1:2000), and β-actin (diluted 1:3000) primary antibodies. The membranes were 
washed and developed with HRP-conjugated secondary antibodies (diluted 1:5000) at room 
temperature. For chemiluminescence studies, immunoreactivity was detected using an 
enhanced chemiluminescent (ECL) solution (Thermo Scientific, IL). Band densities were 
examined using the Multi Gauge 3.1 software (Fuji Photo Film, Tokyo, Japan). 
2.12 Statistical analysis 
All data were assessed with a one-way analysis of variance (ANOVA) followed by 
Dunnett’s multiple comparisons test. The obtained data are presented as the mean ± standard 
error of mean (SEM). A statistical probability of p<0.05 was considered significant using 
GraphPad Prism version 7.00.  
 
3. Results  
3.1 Identification and quantification of the major constituents of R. volubilis 
EERN was injected into the HPLC system and six compounds were detected in the 
HPLC profile with a DAD chromatogram (Figure 1A). The compounds were identified 
according to the mass spectra and retention times relative to the standards [tR 9.0 (1), 13.1 (2), 
14.4 (3), 17.5 (4), 18.2 (5), and 21.0 min (6)]. The mass spectra of the six compounds showed 
a molecular ion [M]
+
 and protonated molecular ions [M+H]
+
 of the standards (Figure 1B). 
The retention time of compounds 1-6 was identical to that of the corresponding standard. The 
six compounds were identified as cyanidin 3-O-glucoside (1), (-)-epicatechin (2), daidzin (3), 
genistin (4), 6″-O-malonyldaidzin (5), and 6″-O-malonylgenistin (6) (Figure 1C). 
The concentration of each constituent was evaluated from the peak area based on the 
calibration curves derived for each compound. The method validation parameters are 
presented in Table 1. Five levels of each standard solution were injected in triplicate to 
establish the calibration curves. The value of correlation coefficients (r
2
) was in the range of 
0.9998–1.0000, indicating good linearity between the peak areas and concentrations. The 
limits of detection (LOD) and quantification (LOQ) were expressed as LOD = 3.3σ/S and 
LOQ = 10σ/S, where σ is the standard deviation of the response and S is the slope of the 
calibration curve of the analyte. Intra- and inter-day variability was determined three times a 
day and on three separate days. Variations are indicated by relative standard deviations 
(RSDs). The accuracy of the method was measured by the recovery of a spiked sample. The 
recovery value was between 96.76 and 100.42%, which is completely acceptable for analysis 
of plant extracts. The amount of each compound was expressed as mg/g of EERV in Table 1. 
The extract of R. volubilis has been standardized to a minimum of 80% to a maximum of 120% 
of the amount of each compound (1‒6). 
 
3.2 Tear film stability and corneal surface damage 
To observe corneal damage caused by BAC treatment, we investigated fluorescein 
staining score and BUT of the ocular surface (Figure 2A–C). The fluorescein staining scores 
increased significantly in the mouse group treated with BAC alone (DE group). However, the 
groups administered EERV (10 and 50 mg/kg) showed reduction in BAC-induced corneal 
damage. Similarly, BUT decreased in the DE group compared to that in the control group 
(Figure 2C). BUT results showed statistical significance, and the 50 mg/kg EERV-treated 
group showed effects similar to the positive control. Histological analysis of the corneal 
tissue was conducted after H&E staining (Figure 2D). Compared to the control, the DE group 
presented corneal epithelial cells with irregular shapes (red circle and arrow). The positive 
control and 50 mg/kg EERV-treated groups ameliorated the irregularity of ocular surface and 
changes in the epithelial cells. According to these results, the oral administration of EERV 
and positive control showed a protective effect in an experimental mouse DE model. 
 
3.3 Inflammation and squamous metaplasia 
To detect inflammation and squamous metaplasia of the corneal tissue, we performed 
immunofluorescence staining (Figure 3). The inflammatory cells in the cornea were stained 
for human leukocyte antigen-DR (HLA-DR). The DE group exhibited increased expression 
of HLA-DR (HLA-DR-stained; red) compared to the control group. The protein level of 
HLA-DR in EERV-treated groups increased dose dependently. We next investigated 
squamous metaplasia induced by inflammatory mediators. To detect squamous metaplasia, 
immunostaining with cytokeratin-10 was performed. The distribution of cytokeratin-10 
expression in the corneal tissue of DE group increased significantly when compared to that of 
the control. Similar to the positive control group, the 50 mg/kg EERV-treated group showed 
protective effects against BAC-induced squamous metaplasia. These findings suggest that 
EERV treatment could inhibit inflammation and squamous metaplasia in an experimental 
mouse DE model. 
 3.4 Apoptosis  
We performed TUNEL assay, which is a useful method for detecting cell death via 
apoptosis (Figure 4A and 4B). The apoptotic cells were detected by their dark nuclear 
staining (TUNEL-positive cells; Green). The DE group showed significant number of 
TUNEL-positive cells (34.25 ± 5.0 cells) compared to the control group. Statistically, few 
TUNEL-positive cells (15.00 ± 4.2 cells) were observed in the 50 mg/kg EERV-treated group, 
and they showed effects similar to the positive control (10.00 ± 2.2 cells). These data 
demonstrated that EERV treatment was effective for cell survival in an experimental mouse 
DE model. 
 
3.5 Expression of apoptosis-associated proteins  
We investigated whether the expression of apoptosis-associated proteins (cytochrome c, 
Bcl-2, and Bax) is regulated by EERV treatment (Figure 5). Western blot analysis was 
conducted in protein lysates from the corneal and conjunctival tissues. The expression of 
cytochrome c and Bax appeared to be higher in the DE group than that in the control group. 
However, these protein levels were significantly downregulated in the EERV-treated group. 
The expression of Bcl-2 in protein lysates was downregulated in the DE group. EERV 
treatment upregulated the expression of Bcl-2 compared to the DE group. These results 
suggested that EERV treatment was effective in protecting against BAC-induced cell death.  
4. Discussion 
DE is a multifactorial ocular surface disease related to oxidative stress (Nakamura et al., 
2007; Wakamatsu et al., 2008). Redox systems are maintained in the corneal epithelial cells 
and tear film (Higuchi et al., 2012). To protect the ocular surface from oxidative stress, anti-
oxidative enzymes are upregulated in the corneal epithelial cells (Offord et al., 1999). 
However, an imbalance of pro-oxidants/antioxidants leads to the overproduction of ROS on 
the ocular surface (Kruk et al., 2015; Ogawa, 2013; Ray et al., 2012). Several researchers 
suggested that natural products used as dietary supplements can minimize the development of 
DE (Andrade et al., 2014; Gatell-Tortajada, 2016; McCusker et al., 2016). Many studies have 
shown that the active constituents of natural products strongly inhibit ROS, which could 
provide beneficial effects against DE. Our previous study has shown that the leaves of 
persimmon (Diospyros kaki) protect the cornea in a BAC-induced DE model (Kim, K.A. et 
al., 2016). Since R. volubilis contains plentiful active constituents including anthocyanins, 
isoflavones, and polyphenols, we expected that it would be beneficial for the treatment or 
prevention of DE. In this study, we showed that EERV protected the cornea in a murine DE 
model.  
The chromatogram of EERV revealed six major peaks (Figure 1A), and the major 
components of EERV were identified as cyanidin 3-O-glucoside, (-)-Epicatechin, daidzin, 
genistin, 6″-O-malonyldaidzin, and 6″-O-malonylgenistin. The chemical composition of a 
plant extract may be affected by various factors, such as seasonal changes, cultivation 
location, harvesting time, post-harvesting process, and extracting procedures. Therefore, 
extract standardization is an important process, where the amount of one or more selected 
compounds can be guaranteed. We carried out the standardization of EERV to compounds 1-6 
as marker compounds. One gram of EERV contains 1.14, 3.11, 1.99, 3.69, 4.84, and 8.95 mg 
of compounds 1-6, respectively. 
BAC is the most widely used preservative to prevent the microbial contamination of eye 
drops (Yu et al., 2008). However, long-term exposure to BAC can lead to severe ocular 
surface changes and has been shown to cause DE in humans (Pauly et al., 2011).  
We used a BAC-induced DE model that showed signs similar to human DE, including 
corneal epithelial apoptosis, instability of tear film, and inflammation (Baudouin et al., 2010; 
Lin et al., 2011). Our results have shown that EERV treatment significantly decreased the 
fluorescein staining score in an experimental mouse DE model (Figure 2A and 2B).  
Instability of the tear film can trigger the overexpression of inflammatory cytokines, such 
as interleukin-6 (IL-6), interleukin-α (IL-α), and HLA-DR in DE (Calonge et al., 2010; 
Epstein et al., 2009; Rolando et al., 2005). HLA-DR is a biomarker of inflammation, and 
upregulated expression of HLA-DR was observed on the ocular surface of DE (Baudouin et 
al., 2000; Lopin et al., 2009; Pisella et al., 2000). We showed that EERV treatment dose-
dependently reduced the expression of HLA-DR compared with the DE group (Figure 3, red). 
Inflammatory cytokines are risk factors associated with the formation of squamous 
metaplasia, which is usually observed in patients with chronic DE (Chen et al., 2009; Murube 
and Rivas, 2003). Increased expression of cytokeratin-10 indicates the presence of squamous 
metaplasia, a condition in which the epithelial cells are converted into a type of keratinizing 
cells in the cornea (Kim, K.A. et al., 2016). The DE group showed increased expression of 
cytokeratin-10 compared to the control group (Figure 3, green). However, EERV treatment 
inhibited the increased expression of cytokeratin-10 in the corneal epithelial layer. These 
results suggested that EERV would reduce inflammation and squamous metaplasia in DE. 
Inflammatory signaling promotes the apoptosis of corneal cells (Li et al., 2012; Strong et 
al., 2005). Inflammation and squamous metaplasia lead to apoptosis signaling cascades (Li et 
al., 2008). Apoptotic cell death is indicated by TUNEL-positive cells (green). In the present 
study, higher number of apoptotic cells was observed in the DE group than in the control 
group (Figure 4A and B). In the positive-control and EERV (50 mg/kg)-treated groups, 
apoptotic cells in the corneal and stromal layers were less than that in the DE group. This 
phenomenon was observed in a previous study, indicating that BAC is a small molecule that 
easily penetrated into the stromal layer from the corneal layer causing apoptotic cell death 
(Kim, K.A. et al., 2016; Kim, Y.H. et al., 2016; Tseng et al., 2016). This study showed that 
EERV treatment at 50 mg/kg was effective in inhibiting apoptosis of the corneal epithelial 
layer, and it would be able to prevent damage to the cornea caused by DE (Figure 4A and B).  
The main apoptotic signals associated with programmed cell death are release of 
cytochrome, upregulation of Bax, and downregulation of Bcl-2 (Katiyar et al., 2005; Sarkar 
et al., 2003). These signals lead to the induction of cell death (Delbridge and Strasser, 2015; 
Kim et al., 2013; Naseri et al., 2015). In a previous study, the expression of the pro-apoptotic 
proteins Bax and cytochrome c increased, while that of Bcl-2, an anti-apoptotic protein, 
decreased in DE (Luo et al., 2007; Sun and Wang, 2006). From the results of this study 
(Figure 5), we can suggest that EERV treatment at 50 mg/kg decreased cytochrome c and Bax 
expression compared with the DE group. Furthermore, Bcl-2 expression was increased by 
EERV treatment (Figure 5). It is suggested that EERV could improve DE because EERV 
treatment regulated the expression of apoptosis-associated proteins. 
R. volubilis is reported to have strong antioxidant activity compared to other soybean 
cultivars (Nam et al., 2014). Previous studies revealed that epicatechin was a major 
antioxidant present in R. volubilis extracts (Jeon et al., 2014; Nam et al., 2014). Epicatechin 
showed more than 100 times stronger hydroxyl radical (·OH) scavenging effect than mannitol, 
a typical ·OH scavenger, and it exerted inhibitory effect on superoxide anion (O2
-
) generation 
in hypoxanthin-xanthin oxidase system (Hanasaki et al., 1994).  
R. volubilis has an abundance of anthocyanins, which are water-soluble natural pigments 
with strong antioxidant activity (Malencic et al., 2012; Song et al., 2013; Xu and Chang, 
2008a, b). The common anthocyanins are cyanidin, delphinidin, petunidin, peonidin, 
malvidin, and pelargonidin. The characteristics of anthocyanins are dependent on the position 
of hydroxylation, methoxylation, and bonded sugar residues. Previous studies showed that the 
hydroxylation position of B (benzene) and C (pyran) rings in anthocyanins play a role in 
increasing antioxidant activity (Lim et al., 2013). Cyanidin and its glycoside derivatives 
inhibited lipid peroxidation, and their antioxidant activities were superior to those of vitamin 
E (Wang et al., 1999). 
Therefore, epicatechin and cyanidin-3-glucoside, being the predominant components 
present in R. volubilis, can either donate hydrogen atoms or transfer a single electron to free 
radicals, which results in ROS scavenging in DE model. However, it is difficult to identify 
the active compounds responsible for the beneficial effects of EERV in DE. Further studies 
are necessary to determine the active compounds of EERV that are effective in DE treatment. 
 
5. Conclusions 
In conclusion, the clinical signs of DE were effectively ameliorated by EERV in an 
experimental mouse DE model. EERV stabilized the ocular surface and maintained the 
integrity of the epithelium. It also provided a protective effect against squamous metaplasia 
and apoptosis in the cornea. Therefore, EERV could be a beneficial agent for the treatment of 
DE diseases. 
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FIGURE LEGENDS 
Figure 1. HPLC-UV chromatogram of EERV (A); MS spectra of major peaks (1–6) acquired 
by positive LC-ESI/MS (B); Identified compounds (C) 
 
Figure 2. Protective effect of EERV on BAC-induced corneal damage. (A) Corneal 
fluorescein staining, (B) fluorescein staining score (C) tear break-up time (BUT), and (D) 
H&E staining were evaluated in all groups. Original magnification: 400 X, scale bars: 50 μm. 
Experimental values are expressed as the mean ± SEM from three independent experiments 
(**p<0.01, ***p<0.001). 
 
Figure 3. Expression of cytokeratin-10 and human leukocyte antigen DR (HLA-DR) in an 
experimental mouse model of dry eye (DE). The corneal sections were stained with anti-
cytokeratin-10 (green) and anti-HLA-DR (red). The nuclei were stained with DAPI, and the 
expression of proteins was examined under a confocal microscope (Original magnification: 
630 X). The results shown are representative of three independent experiments.  
 
Figure 4. Apoptotic cell death in an experimental mouse model of dry eye (DE). (A) The 
corneal sections were stained with a TUNEL kit (Nuclei were stained with DAPI) and 
examined under a confocal microscope (Original magnification, 630 X). TUNEL-positive 
cells (green) indicate apoptotic cell death of the section slides (B) Quantification of TUNEL-
positive cells. Scale bar = 50 μm. Experimental values are expressed as the mean ± SEM 
from three independent experiments (***p<0.001). 
 
Figure 5. Expression of apoptosis-associated proteins. (A) Total protein and 
immunoreactivities of cytochrome c, Bcl-2, Bax, and β-actin (loading control) were examined 
by western blot analysis. (B) Quantification of relative protein levels compared to β-actin 
(loading control). Experimental values are expressed as the mean ± SEM from three 
independent experiments (*p<0.05, **p<0.01). 
 
Table 1. Calibration curve, precision, LOD, LOQ, and contents of Compounds 1-6 in EERV 
Compound 
Linear 
range 
(μg/mL) 
Calibration curve Precision, RSD (%) 
LOD 
(μg/mL) 
LOQ 
(μg/mL) 
Content  
(mg/g 
EERV) 
Regression equation r
2 Intraday 
(n = 3) 
Interday 
(n = 3) 
1 5–160 y = 19.076x - 8.469 1.0000 1.68 1.90 0.58 1.93 1.14 
2 5–160 y = 7.0251x + 6.772 0.9999 0.34 1.35 0.30 1.00 3.11 
3 20-160 y = 44.375x + 78.322 0.9999 0.26 1.21 0.31 1.04 1.99 
4 20-160 y = 60.109x + 136.530 0.9998 0.13 1.17 0.20 0.66 3.69 
5 20-320 y = 25.180x + 80.011 0.9998 3.29 8.05 3.13 10.43 4.84 
6 20-320 y = 32.745x + 113.100 0.9998 2.50 10.61 0.29 0.95 8.95 
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